Combined therapy with azathioprine, prednisolone, and ursodiol in patients with primary sclerosing cholangitis: A case series

Annals of Internal Medicine

Volumn 131, Issue 12, 1999, Pages 943-946

  Schramm, Christoph ^a   Schirmacher, Peter ^a,b   Helmreich Becker, Ilka ^a   Gerken, Guido ^a,c   Zum Büschenfelde, Karl Heinz Meyer ^a   Lohse, Ansgar W ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; LIVER ENZYME; PREDNISOLONE; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ESOPHAGUS VARICES BLEEDING; FEMALE; FEVER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER TOXICITY; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL;

EID: 0033593074     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-131-12-199912210-00006     Document Type: Article

References (20)

1. Chapman RW, Arborgh BA, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, et al. Primary sclerosing cholangitis: a review of its clinical featires, cholangiography and hepatic histology. Gut 1980;21:870-7.
2. Chapman RW. Role of immune factors in the pathogenesis of primary sclerosing cholangitis. Semm Liver Dis. 1991;11:1-4.
3. Wiesner RH. Current concepts in primary sclerosing cholangitis. Mayo Clin Proc. 1994;69:969-82.
4. Lee YM, Kaplan MM. Primary sclerosing rholangitis. N Engl J Med. 1995; 332:924-33.
5. LaRusso NF, Wiesner RH, Ludwig J, MacCarty RL, Beaver SJ, Zinsmeister AR. Prospective trial of penicillamine in primary sclerosing cholangitis. Gastroenteroloqy. 1988;95:1036-42.
6. Olsson R, Broome U, Danielsson A, Hagerstrand I, Jarnerot G, Loof L, et al. Colchicine treatment of primary sclerosing cholangitis. Gastroenterology. 1995;108:1199-203.
7. Knox TA, Kaplan MM. A double-blind controlled trial of oral-pulse methotrexate therapy in tne treatment of primary sclerosing cholangitis. Gastroenterology. 1994;106:494-9.
8. Wiesner RH, Steiner B, LaRusso NF, Lindor KD, Baldus WP. A controlled trial evaluating cydosponne in the treatment of primary sclerosing cholangitis [Abstract]. Hepatology. 1991;14:63.
9. Van Thiel DH, Carroll P, Abu-Elmagd K, Rodriguez-Rilo H, Irish W, McMichael J, et al. Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis results of an open-label preliminary trial. Am J Gastroenterol. 1995;90:455-9.
10. Lindor KD. Ursodiol for ormary sclerosing cholangitis. N Engl J Med. 1997; 336:691-5.
11. Mendel R, Hebestreit HP, Droste R, Bade J, Georgi M. 2 cases of primary sclerosing cholangitis - the ERCP documentation of a 3-year course in immunosuppressive therapy. Radiologe. 1985;25:83-6.
12. Javett SL. Azathiopnne in primary sclerosing cholangitis. Lancet. 1971;1:810.
13. Wagner A. Azathioprine treatment in primary sclerosing cholangitis. Lancet. 1971;2:663-4.
14. Myers RN, Cooper JH, Padis N. Primary sclerosing cholangitis: complete gross and histologic reversal after long-term steroid therapy. Am J Gastroenterol. 1970;53:527-38.
15. Burgert SL, Brown BP, Kirkpatrick RB, LaBreque DR. Positive conticosteroid response in early primary sclerosing cholangitis (Abstract) Gastroenterology. 1984;86:1037.
16. Hayashi H, Higuchi T, Ichimiya H, Hishida N, Sakamoto N. Asymptomatic primary sclerosing cholangitis treated with ursodeoxycholic acid. Gastroenterology. 1990;99:533-5.
17. Beuers U, Spengler U, Kruis W, Aydemir Ü, Wiebecke B, Heldwein W, et al. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo controlled trial. Hepatology. 1992;16:707-14.
18. Stiehl A, Rudolph G, Sauer P, Benz C, Stremmel W, Walker S, et al. Efficacy cf ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study. J Hepatol. 1997;26:560-6.
19. Kaplan MM. Toward better treatment of primary sclerosing cholangitis. N Engl J Med. 1997;336:719-21.
20. Ludwig J, Barham SS, LaRusso NF, Elveback LR, Wiesner RH, McCall JT. Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology. 1981;1:632-40.